The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits
Abstract
Anhedonia is a common, persistent, and disabling condition. However, available therapeutics primarily focus on the reduction of depressive and negative symptoms rather than amelioration of deficits in positive affect. As such, extant drug treatments remain largely ineffective in treating symptoms of anhedonia. Ketamine is a rapid-acting and novel therapeutic treatment for treatment-resistant depression, which has also been demonstrated to attenuate symptoms of anhedonia. However, the literature on the anti-anhedonic effects of ketamine is limited-especially within independent dimensions of this symptom domain. Herein, this review examined the impact of ketamine treatment on anhedonia and its dimensions on anticipatory, consummatory, and motivation-related reward deficits. Overall, the findings have shown a trend towards symptom reduction and/or improvements in anhedonia and their respective subdomains, in both human and preclinical studies, as well as its potential to provide additional benefit in reducing suicidality and improving quality-of-life. Although further research is required in understanding the long-term efficacy and mechanism, ketamine may provide an effective and rapid-acting therapeutic in an otherwise unmet domain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · cited 2×
“, SSRIs, TCAs, and bupropion) do not treat or alleviate symptoms of anhedonia to an effective and/or sufficient degree, nor do they address the nuanced and multidimensional aspects in depression, such as motivational and reward-processing deficits (Belujon and Grace 2017; Perna et al. 2020; Treadway and Zald, 2011; Wa…”
BackgroundThe neurobiology of anhedonia and other reward-related deficits
Der-Avakian, A., & Markou, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.005 · Cited by 1,130 · cited 1×
“According to the DSM-5, a major depressive disorder (MDD) diagnosis is dependent upon the presence of five or more of the recognized symptoms during a 2-week period—of which, at least one of the symptoms must be either depressed mood or anhedonia (Dichter 2010).”
BackgroundMechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · cited 5×
“2021a, b; Zanos and Gould 2018).”
BackgroundInfluentialLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yang, Y., Cui, Y., Sang, K., Dong, Y., Ni, Z., Ma, S., & Hu, H. (2018) · Nature · doi:10.1038/nature25509 · Cited by 1,036
Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure
Gard, D. E., Kring, A. M., Gard, M. G., Horan, W. P., & Green, M. F. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.008 · Cited by 817 · cited 1×
“Furthermore, as pleasure may be experienced and thus, divided into chronological phases, the dimensions of motivation-related, anticipatory, and consummatory anhedonia may be defined as the amount of motivation or effort an individual is willing to exert towards obtaining a reward, whether or not and the degree at whi…”
BackgroundDopamine system dysregulation in major depressive disorders
Belujon, P., & Grace, A. A. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx056 · Cited by 754 · cited 1×
“…(e.g., SSRIs, TCAs, and bupropion) do not treat or alleviate symptoms of anhedonia to an effective and/or sufficient degree, nor do they address the nuanced and multidimensional aspects in depression, such as motivational and reward-processing deficits (Belujon and Grace 2017; Perna et al.”
BackgroundTreadway, M. T., Bossaller, N. A., Shelton, R. C., & Zald, D. H. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0028813 · Cited by 733 · cited 1×
“Furthermore, as pleasure may be experienced and thus, divided into chronological phases, the dimensions of motivation-related, anticipatory, and consummatory anhedonia may be defined as the amount of motivation or effort an individual is willing to exert towards obtaining a reward, whether or not and the degree at whi…”
BackgroundMcIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Self-citationResearch Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior
Morris, S. E., & Cuthbert, B. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.1/smorris · Cited by 638
Research works printed but not linked: 3
- Dichter GS (2010) Anhedonia in unipolar major depressive disorder: a review. In The Open Psychiatry Journal (4)
- Levchuk LA, Meeder EMG, Roschina OV, Loonen AJM, Boiko AS, Michalitskaya EV, Epimakhova EV, Losenkov IS, Simutkin GG, Bokhan NA, Schellekens AFA, Ivanova SA (2020) Exploring brain derived neurotrophic factor and cell adhesion molecules as biomarkers for the transdiagnostic symptom anhedonia in alcohol use disorder and comorbid depression. Front Psych 11:296. https://doi.org/10.3389/FPSYT.2020.00296/BIBTEX · doi:10.3389/fpsyt.2020.00296/bibtex
- Walsh AEL, Huneke NTM, Brown R, Browning M, Cowen P, & Harmer CJ (2018) A dissociation of the acute effects of bupropion on positive emotional processing and reward processing in healthy volunteers. Frontiers in Psychiatry 9(OCT). https://doi.org/10.3389/FPSYT.2018.00482/FULL · doi:10.3389/fpsyt.2018.00482/full
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citation
Metadata
- Authors
- Nogo, D., Jasrai, A. K., Kim, H., Nasri, F., Ceban, F., Lui, L. M. W., Rosenblat, J. D., Vinberg, M., Ho, R., & McIntyre, R. S.
- Affiliations
- University Health Network (CA)
- University of Copenhagen (DK)
- National University of Singapore (SG)
- Corresponding author
- McIntyre, Roger S.
- ORCID
- Venue
- Psychopharmacology
- Published
- 2022-03-15
- Volume
- 239
- Issue
- 7
- Pages
- 2011-2039
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W4220922409
- Cited by
- 54
- References
- 80
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 11 · 2023: 12 · 2022: 6
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, anhedonia, motivation, treatment-resistant depression, rapid-acting antidepressants, suicidality, quality of life
- MeSH terms
- Humans, Ketamine, Motivation, Reward, Anhedonia, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits. https://app.cochat.ai/papers/10.1007/s00213-022-06105-9
- The paper
- Nogo, D., Jasrai, A. K., Kim, H., Nasri, F., Ceban, F., Lui, L. M. W., Rosenblat, J. D., Vinberg, M., Ho, R., & McIntyre, R. S. (2022). The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits. Psychopharmacology. https://doi.org/10.1007/s00213-022-06105-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.